Literature DB >> 25331268

Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: an international systematic review.

Jonathan Feelemyer1, Don Des Jarlais, Kamyar Arasteh, Anneli Uusküla.   

Abstract

Adherence to antiretroviral (ART) medication is vital to reducing morbidity and mortality among HIV positive persons. People who inject drugs (PWID) are at high risk for HIV infection in transitional/low/middle income countries (TLMIC). We conducted a systematic review of studies reporting adherence to ART among persons with active injection drug use and/or histories of injection drug use in TLMIC. Meta-regression was performed to examine relationships between location, adherence measurements, and follow-up period. Fifteen studies were included from seven countries. Adherence levels ranged from 33 to 97 %; mean weighted adherence was 72 %. ART adherence was associated with different methods of measuring adherence and studies conducted in Eastern Europe and East Asia. The great heterogeneity observed precludes generalization to TLMIC as a whole. Given the critical importance of ART adherence more research is needed on ART adherence among PWID in TLMIC, including the use of standardized methods for reporting adherence to ART.

Entities:  

Mesh:

Year:  2015        PMID: 25331268      PMCID: PMC4393761          DOI: 10.1007/s10461-014-0928-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  42 in total

1.  The discovery of HIV as the cause of AIDS.

Authors:  Robert C Gallo; Luc Montagnier
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

2.  Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forward.

Authors:  A Kagee; R H Remien; A Berkman; S Hoffman; L Campos; L Swartz
Journal:  Glob Public Health       Date:  2011

3.  Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania.

Authors:  Gretchen Antelman; Sylvia Kaaya; Ruilan Wei; Jessie Mbwambo; Gernard I Msamanga; Wafaie W Fawzi; Mary C Smith Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-01       Impact factor: 3.731

4.  Enhanced HIV testing, treatment, and support for HIV-infected substance users.

Authors:  Nora D Volkow; Julio Montaner
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

5.  Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting.

Authors:  Dan Werb; M-J Milloy; Thomas Kerr; Ruth Zhang; Julio Montaner; Evan Wood
Journal:  AIDS Behav       Date:  2013-01

6.  Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.

Authors:  Mette Vang Larsen; Lars Haukali Omland; Jan Gerstoft; Birgit T Røge; Carsten Schade Larsen; Gitte Pedersen; Niels Obel; Gitte Kronborg
Journal:  Scand J Infect Dis       Date:  2010-09-15

Review 7.  Combination HIV prevention: significance, challenges, and opportunities.

Authors:  Ann E Kurth; Connie Celum; Jared M Baeten; Sten H Vermund; Judith N Wasserheit
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

8.  Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.

Authors:  M R Jordan; H La; H D Nguyen; H Sheehan; T T M Lien; D V Duong; J Hellinger; C Wanke; A M Tang
Journal:  Int J STD AIDS       Date:  2009-06       Impact factor: 1.359

9.  The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia.

Authors:  Alla V Shaboltas; Roman V Skochilov; Lillian B Brown; Vanessa N Elharrar; Andrei P Kozlov; Irving F Hoffman
Journal:  Harm Reduct J       Date:  2013-09-05

10.  Outcomes of antiretroviral therapy in Vietnam: results from a national evaluation.

Authors:  Duc Bui Nguyen; Nhan Thi Do; Ray W Shiraishi; Yen Ngoc Le; Quang Hong Tran; Hai Huu Nguyen; Nicholas Medland; Long Thanh Nguyen; Bruce Baird Struminger
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

View more
  15 in total

Review 1.  Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

Authors:  M Eugenia Socias; M-J Milloy
Journal:  Curr Infect Dis Rep       Date:  2018-07-31       Impact factor: 3.725

Review 2.  Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa.

Authors:  Sara Sardashti; Mehrnoosh Samaei; Mona Mohammadi Firouzeh; Seyed Ali Mirshahvalad; Fatemeh Golsoorat Pahlaviani; SeyedAhmad SeyedAlinaghi
Journal:  World J Virol       Date:  2015-05-12

3.  The Longitudinal Effects of Non-injection Substance Use on Sustained HIV Viral Load Undetectability Among MSM and Heterosexual Men in Brazil and Thailand: The Role of ART Adherence and Depressive Symptoms (HPTN 063).

Authors:  Kiyomi Tsuyuki; Steven J Shoptaw; Yusuf Ransome; Gordon Chau; Carlos E Rodriguez-Diaz; Ruth K Friedman; Kriengkrai Srithanaviboonchai; Sue Li; Matthew J Mimiaga; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Behav       Date:  2019-03

4.  Stigma and ART initiation among people with HIV and a lifetime history of illicit drug use in Saint-Petersburg, Russia-A prospective cohort analysis.

Authors:  Marina Vetrova; Sara Lodi; Lindsey Rateau; Gregory Patts; Elena Blokhina; Vladimir Palatkin; Tatiana Yaroslavtseva; Olga Toussova; Natalia Bushara; Sally Bendiks; Natalia Gnatienko; Evgeny Krupitsky; Dmitry Lioznov; Jeffrey H Samet; Karsten Lunze
Journal:  Int J Drug Policy       Date:  2022-02-05

5.  Comparative Clinical Outcomes With Scale-up of Dolutegravir as First-Line Antiretroviral Therapy in Ukraine.

Authors:  Kostyantyn Dumchev; Tetiana Kiriazova; Serhiy Riabokon; Alyona Shost; Canada Parrish; Anna Shapoval; Myroslava Germanovych; Jeremy Penner; Jason Beste; Nancy Puttkammer
Journal:  J Acquir Immune Defic Syndr       Date:  2022-10-01       Impact factor: 3.771

6.  HIV care continuum among men who have sex with men and persons who inject drugs in India: barriers to successful engagement.

Authors:  Shruti H Mehta; Gregory M Lucas; Suniti Solomon; Aylur K Srikrishnan; Allison M McFall; Neeraj Dhingra; Paneerselvam Nandagopal; M Suresh Kumar; David D Celentano; Sunil S Solomon
Journal:  Clin Infect Dis       Date:  2015-08-06       Impact factor: 9.079

Review 7.  Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugs.

Authors:  Surita Parashar; Alexandra B Collins; Julio S G Montaner; Robert S Hogg; Michael-John Milloy
Journal:  Curr Opin HIV AIDS       Date:  2016-09       Impact factor: 4.283

8.  Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States.

Authors:  Harinder S Chahal; Marion G Peters; Aaron M Harris; Devon McCabe; Paul Volberding; James G Kahn
Journal:  Open Forum Infect Dis       Date:  2018-12-26       Impact factor: 3.835

9.  Prevalence and longitudinal correlates of recent exposure to fentanyl among HIV-positive people who use unregulated drugs during a community-wide overdose crisis.

Authors:  Soroush Moallef; Ekaterina Nosova; Seonaid Nolan; Nadia Fairbairn; Jane Loh; Kanna Hayashi; M-J Milloy
Journal:  AIDS Care       Date:  2021-03-25

10.  An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis.

Authors:  Nyashadzaishe Mafirakureva; Jack Stone; Hannah Fraser; Yvonne Nzomukunda; Aron Maina; Angela W Thiong'o; Kibango Walter Kizito; Esther W K Mucara; C Inés González Diaz; Helgar Musyoki; Bernard Mundia; Peter Cherutich; Mercy Nyakowa; John Lizcano; Nok Chhun; Ann Kurth; Matthew J Akiyama; Wanjiru Waruiru; Parinita Bhattacharjee; Charles Cleland; Dmytro Donchuk; Niklas Luhmann; Anne Loarec; David Maman; Josephine Walker; Peter Vickerman
Journal:  Addiction       Date:  2021-07-28       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.